https://scholars.lib.ntu.edu.tw/handle/123456789/413729
標題: | Gamma knife radiosurgery for central neurocytoma: Retrospective analysis of fourteen cases with a median follow-up period of sixty-five months | 作者: | Chen M.-C. Pan D.H.-C. Chung W.-Y. Liu K.-D. Yen Y.-S. Chen M.-T. Wong T.-T. Shih Y.-H. Wu H.-M. Guo W.-Y. Shiau C.-Y. Wang L.-W. Lin C.-W. |
關鍵字: | Central neurocytoma; Gamma knife radiosurgery; Radiation effect; Radiotherapy | 公開日期: | 2011 | 卷: | 89 | 期: | 3 | 起(迄)頁: | 185-193 | 來源出版物: | Stereotactic and Functional Neurosurgery | 摘要: | Object: Central neurocytoma (CN) is considered to be a benign neuronal tumor with possible atypical behavior. Microsurgery, radiation therapy (RT) and radiosurgery all have been used in treating this rare disease during the past decade. In this study, the authors present the experience with gamma knife radiosurgery (GKRS) on 14 patients with CN during a median follow-up period of 65 months and document the safety and efficacy of GKRS in the treatment of CN. Methods: Between November 1997 and December 2009, 14 patients pathologically diagnosed with CN were treated with GKRS. Follow-up magnetic resonance imaging (MRI) was performed at 6-month intervals. Tumor volume and adverse radiation effects (ARE) were documented to evaluate tumor response to GKRS. The Karnofsky Performance Scale (KPS) and neurological status were used to assess clinical outcome. The mean radiation dose prescribed to the tumor margin was 12.1 Gy (ranging from 11 to 13 Gy). The mean tumor volume was 19.6 ml (ranging from 3.5 to 48.9 ml). The mean follow-up period was 70 months (ranging from 30 to 140 months), and the median follow-up period was 65 months. Results: Tumor shrinkage was found in all patients at the final MRI follow-up. The mean volume reduction was 69% (ranging from 47 to 87%). No tumor progression, ARE or radiation-related toxicity developed in any of the cases. The KPS scores of all patients were the same or had increased, and the neurological functions were all stable without deterioration at the final follow-up. Conclusion: In our observations, GKRS was found to be an effective and safe alternative as adjuvant therapy for pathology-confirmed CN. The tumor volume and functional outcome can be controlled with a favorable result in long-term observation. Compared with RT and microsurgery, GKRS plays an important role in the treatment of CN as a minimally invasive technique with low morbidity. Regular long-term MRI follow-up should be mandatory to document the tumor response and possible recurrence. Multicenter consortia should be considered for further investigation and evaluation of GKRS for such a rare tumor. Copyright ? 2011 S. Karger AG. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955563020&doi=10.1159%2f000326780&partnerID=40&md5=8c2b25fa21f49dfcfbc7edf8bee5e96f https://scholars.lib.ntu.edu.tw/handle/123456789/413729 |
ISSN: | 10116125 | DOI: | 10.1159/000326780 | SDG/關鍵字: | adult; adverse outcome; article; brain function; brain surgery; cancer patient; cancer tissue; child; clinical article; clinical effectiveness; female; follow up; gamma knife radiosurgery; headache; histopathology; human; human tissue; Karnofsky Performance Status; lethargy; male; neuroepithelioma; nuclear magnetic resonance imaging; patient safety; preschool child; radiation dose; retrospective study; treatment response; tumor regression; tumor volume; Adolescent; Adult; Brain Neoplasms; Child, Preschool; Female; Follow-Up Studies; Humans; Male; Neurocytoma; Radiosurgery; Retrospective Studies; Treatment Outcome |
顯示於: | 醫學工程學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。